By Fineline Cube 
Yanyin Tech and Shanghai CirCode Biomed Co. Ltd. have announced a three-year strategic cooperation agreement aimed at advancing the development of RNA drugs through the integration of AI technology.
Collaboration Framework
The partnership will leverage a digital platform to explore AI applications in RNA drug development, focusing on accelerating innovation and establishing a new paradigm for intelligent R&D.
Digital Foundation and AI Integration
CirCode has implemented Yanyin’s “Yanyin AI R&D Cloud” platform, utilizing its Electronic Lab Notebook (ELN) and Sample Management modules. This digital foundation will support deeper collaboration to explore AI’s potential in circRNA drug development.-Fineline Info & Tech